Highline Wealth Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.2K | Sell |
403
-13
| -3% | -$908 | 0.01% | 178 |
|
|
2025
Q1 | $30.6K | Buy |
416
+340
| +447% | +$25K | 0.01% | 163 |
|
|
2024
Q4 | $4.98K | Sell |
76
-123
| -62% | -$8.06K | ﹤0.01% | 340 |
|
|
2024
Q3 | $15.5K | Buy |
199
+87
| +78% | +$6.78K | 0.01% | 210 |
|
|
2024
Q2 | $8.74K | Buy |
112
+92
| +460% | +$7.18K | ﹤0.01% | 239 |
|
|
2024
Q1 | $1.36K | Hold |
20
| – | – | ﹤0.01% | 351 |
|
|
2023
Q4 | $1.35K | Hold |
20
| – | – | ﹤0.01% | 324 |
|
|
2023
Q3 | $1.35K | Buy |
+20
| New | +$1.35K | ﹤0.01% | 294 |
|